← Back to Clinical Trials
Recruiting NCT06553716

Ultrasound-Guided Hydrodilatation With Triamcinolone Acetonide for Adhesive Capsulitis

Trial Parameters

Condition Postoperation Pain
Sponsor General Hospital of Ningxia Medical University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 70
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-02-05
Completion 2024-10-30
Interventions
Ultrasound-Guided Hydrodilatation by the Rotator cuff interval recessUltrasound-Guided Hydrodilatation by the Rotator cuff interval and posterior glenohumeral recess

Brief Summary

The purpose of this study was to compare the efficacy of ultrasus-guided hydrodilation of Rotator Cuff Interval combined with Posterior Glenohumeral recess approach and hydrodilation of the Rotator cuff Interval alone in Adhesive Capsulitis.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥18 years old, clinical diagnosis of periarthritis of shoulder; 2. symptom duration \> 1 month, shoulder ROM limitation in at least two directions, defined as abduction \< 80°, flexion \< 130°, and rotation \< 30°; 3. Before enrollment, the patients received plain radiographs, ultrasound images, and magnetic resonance imaging to rule out the cause of secondary shoulder capsitis. Exclusion Criteria: 1. Secondary frozen shoulder, such as rotator cuff tear, calcifying tendinitis, osteoarthritis, infection, tuberculosis infection, rheumatic disease, shoulder impingement syndrome; 2. Previous history of shoulder joint surgery; 3. Involved cervical nervous system symptoms or abnormal nervous system; 4. corticosteroid injection in the affected shoulder within 3 months; 5. Mental illness; 6. Patients with contraindications to cortisol-hormone use.

Related Trials